Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunction
批准号:
8318856
负责人:
Rafick Pierre Sekaly
金额:
$26.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2013-08-31
关键词:
AcuteAffectAgonistAntibodiesAntigen-Presenting CellsBiochemicalBiological AssayCD28 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell CountCell ProliferationCell physiologyCellsChronicChronic PhaseCollaborationsComplexCytoplasmic TailDataDefectDiseaseDominant-Negative MutationEnergy TransferEpitopesFluorescenceFluorescence MicroscopyFluorescence Resonance Energy TransferFrequenciesFunctional disorderGene ExpressionGenerationsHIVHIV InfectionsHIV-1HumanImageImmuneImmune System DiseasesImmune responseImmune systemImmunoprecipitationIndividualInfectionLeadLifeLigandsLigationLipid BilayersLymphocytic choriomeningitis virusMemoryMolecularMonitorMusMutateMutationNatural HistoryPTPN11 genePTPN6 genePathway interactionsPatientsPeptidesPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPopulationProductionProtein Tyrosine KinaseRNA InterferenceRecruitment ActivityRegulationReportingSignal PathwaySignal TransductionSignaling MoleculeStagingSynapsesSystemT memory cellT-Cell ActivationT-Cell Activation PathwayT-LymphocyteT-Lymphocyte SubsetsTestingTyrosine PhosphorylationUp-RegulationValidationViralVirusVirus DiseasesWestern Blottingcell typecellular imagingcrosslinkcytokineexhaustexhaustionimmunological synapseimmunological synapse formationinduced pluripotent stem cellnew therapeutic targetoverexpressionpreventreconstitutionresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In HIV infection a large frequency of HIV specific CD8+ and CD4+ T lymphocytes are dysfunctional and
coincidentally show an increased expression of the negative regulator of T cell activation PD-1, PD1 ligation
by PD-L1 and PD-L2 leads to the inhibition of most T cell functions including proliferation, cytokine
production and survival. However, the molecular mechanisms downstream of PD-1 remain unknown. The
major objective of this project is to define the molecular mechanisms that render T cells dysfunctional
following PD-1 ligation and to identify strategies that will allow the rescue of such dysfunction in HIV specific
CD8 cells. We will test the hypothesis that PD1 interferes with upstream TCR signaling pathways in order
to affect all T cell functions. We have shown that PD-1 ligation leads to the phosphorylation of SHP-1 and
SHP-2 phosphatases. Moreover PD1 crosslinking leads to the inhibition of p56Lck activation through the
phosphorylation of the tyrosine Y505 by the inhibitory kinase Csk. In Specific Aim 1 we will determine the
proximal signaling defect in PD-1 hi exhausted cells from HIV infected patients and assess whether Csk is
recruited to the immunological synapse by PD1 ligation or whether it is released from Cbp/PAG by the SHP-
2 phosphatase. We will determine by quantitative immunoprecipitation if the inhibitory kinase Csk and the in
phosphatases SHP-1 and SHP-2 are recruited to the TCR complex. Fluorescence (Forster) resonance
energy transfer (FRET) experiments will be carried out to identify the partners involved in the negative
regulation of p56Lck activity. The recruitment of these negative regulators will be assessed in cells showing
varying degrees of dysfunction . We will use siRNAs specific for Csk, SHP-1, SHP-2 and Fyn-T and
activated forms of Lck to rescue T cell function in T cells at the extremes of this gradient of dysfunction. In
Aim 2, live cell imaging using total internal reflection fluorescence microscopy (TIRFM) will be used to
visualize, (in collaboration with Core C) the dynamics of the immunological synapse formation upon PD-1
crosslinking in HIV specific CD8+ T cells showing varying degrees of dysfunction. . We will assess whether
inhibition of the kinase Csk and the phosphatases SHP-112 will restore the integrity of the synapse as
observed in efficiently activated T cells. Results emanating from this project may lead to the identification of
novel therapeutic targets that can allow immune reconstitution during HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
-
批准号:10731665
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10588314
-
项目类别:
-
资助金额:$79.33万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
-
批准号:10731661
-
项目类别:
-
资助金额:$129.39万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
MOIR - Administrative Core
-
批准号:10731662
-
项目类别:
-
资助金额:$9.62万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
I2 Control= Modulating Innate Immunity to Achieve Control of HIV
-
批准号:10731664
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429404
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596182
-
项目类别:
-
资助金额:$8.72万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
-
批准号:10341373
-
项目类别:
-
资助金额:$104.7万
-
财政年份:2021
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
-
批准号:10163555
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222321
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir
-
批准号:10321500
-
项目类别:
-
资助金额:$74.39万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
-
批准号:10321501
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680632
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10080706
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10322684
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9623814
-
项目类别:
-
资助金额:$87.52万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10198704
-
项目类别:
-
资助金额:$154.03万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9979743
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10336870
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10463861
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
海外基金